ahlam1399
07-21-2016, 11:52 AM
UPDATE 1-Galenica to buy biotech firm Relypsa for $1.5 bln before break-up
July 21 (Reuters) - Galenica has agreed to buy U.S.biotech firm Relypsa for $1.53 billion in cash tostrengthen its Vifor Pharma unit ahead of splitting up the Swisshealthcare group.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=fhXeK5fzLHc:F7Iq4wYGHDE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fhXeK5fzLHc:F7Iq4wYGHDE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=fhXeK5fzLHc:F7Iq4wYGHDE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fhXeK5fzLHc:F7Iq4wYGHDE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=fhXeK5fzLHc:F7Iq4wYGHDE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/fhXeK5fzLHc
July 21 (Reuters) - Galenica has agreed to buy U.S.biotech firm Relypsa for $1.53 billion in cash tostrengthen its Vifor Pharma unit ahead of splitting up the Swisshealthcare group.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=fhXeK5fzLHc:F7Iq4wYGHDE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fhXeK5fzLHc:F7Iq4wYGHDE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=fhXeK5fzLHc:F7Iq4wYGHDE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fhXeK5fzLHc:F7Iq4wYGHDE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=fhXeK5fzLHc:F7Iq4wYGHDE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/fhXeK5fzLHc